AUA 2007 Meeting Podcast &$8212; Day 5

Listen to the Urology Times Radio podcast from Day Five of the 2007 AUA Annual Meeting in Anaheim, California. This podcast includes interviews with highly regarded experts in urological medicine including: Daniel Kaplon, MD, reports on the risk of osteopenia in infertile men Stanton Honig, MD, discusses patients' understanding of male infertilityPeter Chan, MD, explains why routine semen analysis fails to predict reproductive outcomes

Related Videos

Related Content

Advertisement

January 15th 2025

EU approves Mona Lisa 2.0 robotic system for prostate cancer

Hannah Clarke

The Mona Lisa 2.0 platform has been previously approved in the US, Australia, and Singapore.

January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

January 14th 2025

FDA grants 510(k) clearance to RELIEF stent for vesicoureteral reflux

Hannah Clarke

In a recent study of the RELIEF stent, 95% of patients showed no VUR following stent placement.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

January 13th 2025

FDA accepts NDA for 3-month leuprolide mesylate formulation for advanced prostate cancer

Hannah Clarke

The PDUFA target action date has been set for August 29, 2025.

January 13th 2025

Enrollment goal met in trial of Urocross Expander Implant for BPH-related LUTS

Hannah Clarke

The Expander-2 trial is intended to provide data that will support submission of the device for regulatory approval.

Related Content

Advertisement

January 15th 2025

EU approves Mona Lisa 2.0 robotic system for prostate cancer

Hannah Clarke

The Mona Lisa 2.0 platform has been previously approved in the US, Australia, and Singapore.

January 14th 2025

Episode 2 Podcast: Managing Overactive Bladder: From Dual Diagnoses to Geriatric Challenges

Wayne Kuang, MD Steven Maislos, MD

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life considerations to optimize patient outcomes.

January 14th 2025

FDA grants 510(k) clearance to RELIEF stent for vesicoureteral reflux

Hannah Clarke

In a recent study of the RELIEF stent, 95% of patients showed no VUR following stent placement.

November 27th 2024

Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults

Wayne Kuang, MD Bilal Chughtai, MD

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

January 13th 2025

FDA accepts NDA for 3-month leuprolide mesylate formulation for advanced prostate cancer

Hannah Clarke

The PDUFA target action date has been set for August 29, 2025.

January 13th 2025

Enrollment goal met in trial of Urocross Expander Implant for BPH-related LUTS

Hannah Clarke

The Expander-2 trial is intended to provide data that will support submission of the device for regulatory approval.